As an interesting perspective in the field of cancer therapy, we have recently identified an inhibitor of UHRF1 (a uracil derivative) that targets the SRA domain with subsequent impact on DNMT1/UHRF1 interactions and decrease in global DNA methylation [24]. This evidence concerns the gene UHRF1 and cancer.